FIELD: chemistry.
SUBSTANCE: invention relates to compounds of general formula
(where values of radicals are given in the claim), as well as salts of such compounds and pharmaceutical compositions based on such compounds. The described compounds exhibit type 1 channel antagonists with transient receptor potential (TRPV1).
EFFECT: compounds can be used to treat diseases and conditions causing pain.
30 cl, 255 ex, 40 tbl
Title | Year | Author | Number |
---|---|---|---|
CRYSTAL SUBSTANCE OF HETEROCYCLIDENACETAMIDE DERIVATIVE | 2018 |
|
RU2779198C2 |
METHOD OF PRODUCING HETEROCYCLIDENE ACETAMIDE DERIVATIVE | 2020 |
|
RU2813203C2 |
HETEROCYCLIC DERIVATIVES AND USE THEREOF | 2015 |
|
RU2711502C2 |
BENZOPYRAZINE AND BENZOXEPINE PI3K INHIBITORS AND USE THEREOF | 2009 |
|
RU2506267C2 |
METHODS FOR PRODUCTION OF RACEMIC AMINOSUBSTITUTED 5,6,7,8-TETRAHYDROQUINOLINE OR RACEMIC AMINOSUBSTITUTED 5,6,7,8-TETRAHYDROISOQUINOLINE, METHODS FOR SEPARATION AND RACEMIZATION THEREOF, METHODS FOR PRODUCTION OF KETOSUBSTITUTED 5,6,7,8-TETRAHYDROQUINOLINE OR KETOSUBSTITUTED 5,6,7,8-TETRAHYDROISOQUINOLINE, METHOD FOR PRODUCTION OF ENANTIOMER PF CONDENSED BYCYCLIC RING SUBSTITUTED WITH PRIMARY AMINE, 5,6,7,8-TETRAHYDROQUINOLINE DERIVATIVES | 2002 |
|
RU2308451C2 |
METHOD OF SYNTHESISING DERIVATIVES OF AMINO-METHYL TETRALIN | 2009 |
|
RU2512285C2 |
QUINOXALINES AND AZAQUINOXALINES AS CRTH RECEPTOR MODULATORS | 2011 |
|
RU2589709C2 |
PYRIDYLALKENE AND PYRIDYLALKYNE ACID AMIDES, METHODS OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD OF ITS PREPARING | 1997 |
|
RU2200734C2 |
ARYLSULFONYLMETHYL OR ARYLSULFONAMIDE DERIVATIVES OF AROMATICS, PHARMACEUTICAL COMPOSITION BASED ON THEM AND WAY OF TREATMENT AGAINST ABNORMALITIES RESPONSIVE TO DOPAMINE D RECEPTOR LIGAND TREATMENT, WITH THEIR HELP | 2005 |
|
RU2442781C2 |
AMINOPYRIDINE-CONTAINING SPLEEN TYROSINE KINASE (SYK) INHIBITORS | 2012 |
|
RU2612217C2 |
Authors
Dates
2012-05-20—Published
2006-07-24—Filed